Loading...
•
Sep 30, 2022
AdaptHealth Q3 2022 Earnings Report
Announced third quarter results and updated 2022 outlook.
Key Takeaways
AdaptHealth Corp. reported a solid third quarter, capitalizing on strong demand in HME and Sleep product lines, with CPAP patient set-ups near record levels and double-digit growth in the diabetes product line. Operational excellence initiatives partially offset inflationary pressures, leading to sequential margin expansion.
Non-acquired net revenue for the third quarter increased 6.1% over the third quarter of 2021.
The company is updating its previously issued financial guidance for fiscal year 2022.
Total capital expenditures representing 10-12% of net revenue (previously 9-11%).
Guidance for fiscal year 2022 does not include any contribution from acquisitions that have not yet closed.
Forward Guidance
The Company is updating its previously issued financial guidance for fiscal year 2022. Total capital expenditures representing 10-12% of net revenue (previously 9-11%). Guidance for fiscal year 2022 does not include any contribution from acquisitions that have not yet closed.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...